公司资料
Carisma Therapeutics, Inc. 股价、新闻与催化剂
- 股票代码:
- CARM
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
0.00 USD (-47.83%)
收盘价
最后更新: 2026年8月21日
—
市值
股价为何变动
As of Aug 21, 2026, CARM closed down 47.8% at $0.0012. No new same-company headline was identified in the current news window.
公司概览
业务概览
Carisma Therapeutics is a cell-therapy company focused on engineered macrophages and cancer immunotherapy. Its story centers on using a novel immune-cell approach to attack tumors.
所在地与行业分类
Carisma is headquartered in the United States and listed on NASDAQ. It sits in cell therapy and oncology biotechnology.
商业模式特征
The company depends on clinical validation, manufacturing feasibility, and capital support while it advances a narrow pipeline. Investors watch early data and platform differentiation.
生物医药行业定位
Carisma occupies a specialized macrophage-cell-therapy niche within biotech. It is catalyst-sensitive because the platform still needs to prove itself clinically.
未来催化剂
- Carisma’s catalysts are macrophage-engineering programs and any strategic or clinical update that clarifies the company’s next path. The company still needs stronger human proof.
近期新闻
- 01
- 02
- 03
- 04
- 05
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。